Mahajan Neuro Centre And General Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-07-2024
- Paid Up Capital ₹ 0.93 M
as on 09-07-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 0.30 M
as on 09-07-2024
- Revenue 28.38%
(FY 2020)
- Profit 88.05%
(FY 2020)
- Ebitda 65.31%
(FY 2020)
- Net Worth 31.57%
(FY 2020)
- Total Assets 37.47%
(FY 2020)
About Mahajan Neuro Centre And General Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.93 M.
The company has closed loans amounting to ₹0.30 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajesh Mahajan and Renu Mahajan serve as directors at the Company.
- CIN/LLPIN
U85110UP2005PTC030220
- Company No.
030220
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2005
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Bareilly, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Mahajan Neuro Centre And General Hospital?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Mahajan  | Director | 27-Jun-2005 | Current |
| Renu Mahajan | Director | 27-Jun-2005 | Current |
Financial Performance of Mahajan Neuro Centre And General Hospital.
Mahajan Neuro Centre And General Hospital Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 28.38% increase. The company also saw a substantial improvement in profitability, with a 88.05% increase in profit. The company's net worth Soared by an impressive increase of 31.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mahajan Neuro Centre And General Hospital?
In 2020, Mahajan Neuro Centre And General Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 22 Nov 2006 | ₹0.30 M | Satisfied |
How Many Employees Work at Mahajan Neuro Centre And General Hospital?
Mahajan Neuro Centre And General Hospital has a workforce of 19 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahajan Neuro Centre And General Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahajan Neuro Centre And General Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
